BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26427043)

  • 1. DOT1L: a new therapeutic target for aggressive breast cancer.
    Lee JY; Kong G
    Oncotarget; 2015 Oct; 6(31):30451-2. PubMed ID: 26427043
    [No Abstract]   [Full Text] [Related]  

  • 2. DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression.
    Cho MH; Park JH; Choi HJ; Park MK; Won HY; Park YJ; Lee CH; Oh SH; Song YS; Kim HS; Oh YH; Lee JY; Kong G
    Nat Commun; 2015 Jul; 6():7821. PubMed ID: 26199140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancer.
    Zhang L; Deng L; Chen F; Yao Y; Wu B; Wei L; Mo Q; Song Y
    Oncotarget; 2014 Nov; 5(21):10665-77. PubMed ID: 25359765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and development.
    Barry ER; Corry GN; Rasmussen TP
    Expert Opin Ther Targets; 2010 Apr; 14(4):405-18. PubMed ID: 20230194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided DOT1L probe optimization by label-free ligand displacement.
    Yi JS; Federation AJ; Qi J; Dhe-Paganon S; Hadler M; Xu X; St Pierre R; Varca AC; Wu L; Marineau JJ; Smith WB; Souza A; Chory EJ; Armstrong SA; Bradner JE
    ACS Chem Biol; 2015 Mar; 10(3):667-74. PubMed ID: 25397901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dot1L mediated histone H3 lysine79 methylation is essential to meiosis progression in mouse oocytes.
    Wang X; Gao W; Ma X; Wang X; Song C; Huang X; Liu H
    Neuro Endocrinol Lett; 2014; 35(6):523-30. PubMed ID: 25433842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Wnt signaling target gene expression by the histone methyltransferase DOT1L.
    Gibbons GS; Owens SR; Fearon ER; Nikolovska-Coleska Z
    ACS Chem Biol; 2015 Jan; 10(1):109-14. PubMed ID: 25361163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of epigenetic mechanisms in epithelial-to-mesenchymal transition of breast cancer cells.
    Nickel A; Stadler SC
    Transl Res; 2015 Jan; 165(1):126-42. PubMed ID: 24768944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines.
    Oktyabri D; Ishimura A; Tange S; Terashima M; Suzuki T
    Biochimie; 2016 Apr; 123():20-31. PubMed ID: 26783998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
    Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
    J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition.
    Kühn MW; Hadler MJ; Daigle SR; Koche RP; Krivtsov AV; Olhava EJ; Caligiuri MA; Huang G; Bradner JE; Pollock RM; Armstrong SA
    Haematologica; 2015 May; 100(5):e190-3. PubMed ID: 25596271
    [No Abstract]   [Full Text] [Related]  

  • 12. Substituted purine and 7-deazapurine compounds as modulators of epigenetic enzymes: a patent evaluation (WO2012075381).
    Lipka DB; Kuck D; Kliem C; Gerhauser C
    Expert Opin Ther Pat; 2013 Apr; 23(4):537-43. PubMed ID: 23448241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition and drug resistance in breast cancer (Review).
    Huang J; Li H; Ren G
    Int J Oncol; 2015 Sep; 47(3):840-8. PubMed ID: 26202679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.
    Zhang X; Zhao X; Shao S; Zuo X; Ning Q; Luo M; Gu S; Zhao X
    Int J Oncol; 2015 Mar; 46(3):1141-8. PubMed ID: 25544568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery in rare indications: opportunities and challenges.
    Richon VM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():19-23. PubMed ID: 24319157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memorable transcription.
    Turner BM
    Nat Cell Biol; 2003 May; 5(5):390-3. PubMed ID: 12724774
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.
    Jacinto FV; Ballestar E; Esteller M
    Oncogene; 2009 Nov; 28(47):4212-24. PubMed ID: 19734945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.
    Katz TA; Vasilatos SN; Harrington E; Oesterreich S; Davidson NE; Huang Y
    Breast Cancer Res Treat; 2014 Jul; 146(1):99-108. PubMed ID: 24924415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.